Investigating the Effects of a Spinal Mobilisation Intervention in People With Lower Back Pain
NCT ID: NCT04012970
Last Updated: 2019-11-29
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
40 participants
INTERVENTIONAL
2016-07-01
2016-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The objective of this study is to measure and analyse the acute effect of a spinal mobilisation intervention on muscle tissue quality in people with lower back pain. The intervention consists of the mobilisation of the lumbar spine for 30 minutes, at a specific rate and pressure. This will be performed by a chartered physiotherapist. This will be tested with 40 participants with lower back pain. This was the recommended sample size given by G Power for a medium effect size, a power of 0.95 and alpha level of 0.05.
Participants will take part in an intervention and a control condition. Lumbar muscle response will be measured for stiffness, tone and elasticity immediately before and after the intervention and the control. The control session consists of lying still for the 30 minutes. Results for both sessions will then be compared. A myometer (MyotonPRO) will be used to assess the change in lumbar muscle objectively. This is a non-invasive, handheld device with many reliability studies on its functionality. Analysis will consider the degree of muscle response with individual covariates involved. This includes gender, height, weight, waist circumference, BMI and level of back pain (discerned by score on Oswestry Disability Index).
The results will compared in 2-way repeated measures, within participant ANOVA for significant differences between conditions and time. Anthropometric measures will be analysed in separate ANOCOVAs to determine any significant factors contributing to level of change.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
A - Intervention then control
Intervention (30 minutes spinal mobilisations) received in first session, then control (30 minutes lying still) received in second session.
Manual spinal mobilisations
B - Control then intervention
Control (30 minutes lying still) received in first session, then intervention (30 minutes spinal mobilisations) received in second session.
Manual spinal mobilisations
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Manual spinal mobilisations
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* segment instability
* infectious disease
* osteomyelitis
* bone tumours
* neurological deficit
* upper motor neuron lesion
* spinal cord damage
* cervical arterial dysfunction
Respond positively to relative contra-indications, excluded based on severity, including:
* osteoporosis
* spinal instability
* rheumatoid arthritis
* inflammatory disease
* active history of cancer
* hypermobile syndrome
* segment hypermobility
* cardiovascular disease
* cervical anomalies
* nerve root disorder
* spinal surgery
* respiratory problems
* thrombosis
* open wounds
* local infection
* fractures or dislocations
16 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Scottish Hospital Endowments Research Trust
OTHER
Pacla Medical Ltd
INDUSTRY
Edinburgh Napier University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Rebecca Hamilton
Principal Investigator, PhD student
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Susan Brown
Role: STUDY_DIRECTOR
Director of PhD Studies
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Edinburgh Napier University
Edinburgh, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PILOT_LBP_1
Identifier Type: -
Identifier Source: org_study_id